Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), ...

VICTORIA, Seychelles, March 20, 2025 (GLOBE NEWSWIRE) -- BTSE Group, a leading global provider of blockchain asset trading ...